Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA

Watchlist Manager
Kiniksa Pharmaceuticals Ltd Logo
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Watchlist
Price: 22.15 USD -2.08% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Kiniksa Pharmaceuticals Ltd?
Write Note

Kiniksa Pharmaceuticals Ltd
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kiniksa Pharmaceuticals Ltd
Operating Expenses Peer Comparison

Comparables:

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
Kiniksa Pharmaceuticals Ltd
NASDAQ:KNSA
Operating Expenses
-$357.7m
CAGR 3-Years
-24%
CAGR 5-Years
-15%
CAGR 10-Years
N/A

See Also

What is Kiniksa Pharmaceuticals Ltd's Operating Expenses?
Operating Expenses
-357.7m USD

Based on the financial report for Sep 30, 2024, Kiniksa Pharmaceuticals Ltd's Operating Expenses amounts to -357.7m USD.

What is Kiniksa Pharmaceuticals Ltd's Operating Expenses growth rate?
Operating Expenses CAGR 5Y
-15%

Over the last year, the Operating Expenses growth was -51%. The average annual Operating Expenses growth rates for Kiniksa Pharmaceuticals Ltd have been -24% over the past three years , -15% over the past five years .

Back to Top